GCG and diabetes mellitus: Given the development of new commercialized method which may improve reproducibility of circulating glicentin measurement, it would be worth investigating its variation in large cohorts of patients and different types of diabetes to evaluate its potential usefulness as non-invasive biomarker of the disease.